Xylem reports seven percent organic revenue increase and strong double-digit growth in 1st quarter 2018 earnings
- First quarter 2018 reported net income was
$79 million or$0.43 per share; Adjusted net income for the quarter was$93 million or$0.51 per share, up 31 percent versus the prior year period - Xylem delivered
$1.2 billion in first quarter 2018 revenue, up 14 percent year-over-year including the impact of foreign exchange and acquisitions - Orders increased 10 percent organically
- Reported and adjusted EBITDA increased 110 and 130 basis points, respectively
“Focused execution and increased collaboration by our teams resulted in
a strong start to 2018,” said
Full-year 2018 Outlook
Xylem continues to forecast full-year 2018 revenue in the range of
Full-year 2018 adjusted operating margin is expected to be in the range
of 13.9 to 14.3 percent, resulting in adjusted earnings per share of
First Quarter Segment Results
Water Infrastructure
Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.
-
First quarter 2018 revenue was
$480 million , up nine percent organically compared with first quarter 2017. This growth includes strong results in the utilities end market, particularly in the U.S. which was up 10 percent. The industrial end market also continued to show solid growth, reflecting healthy market conditions in the U.S. for dewatering applications. -
First quarter reported operating income for the segment was
$49 million . Adjusted operating income for the segment, which excludes$5 million of restructuring and realignment costs, was$54 million , a 20-percent increase over the same period a year ago. Adjusted EBITDA for the Water Infrastructure segment increased 30 basis points to 14.6 percent. Reported operating margin for the segment was 10.2 percent, up 40 basis points versus the prior year, and adjusted operating margin increased 60 basis points to 11.3 percent. This growth reflects volume leverage and productivity gains, partially offset by inflation, a higher mix of treatment project deliveries and foreign exchange impacts.
Applied Water
Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial applications.
-
First quarter 2018 Applied Water revenue was
$366 million , a seven-percent increase organically year-over-year. This performance reflects double-digit growth inWestern Europe and solid increases in the U.S. and Emerging Markets. In the U.S., the business experienced continued improvement in large industrial projects, and also captured share gains across all end markets inWestern Europe . In addition, commercial building applications showed solid growth from demand for projects. -
First quarter reported operating income for the segment was
$50 million and adjusted operating income, which excludes$3 million of restructuring and realignment costs, was$53 million , an 18-percent increase over the comparable period last year. Adjusted EBITDA for the Applied Water segment was 16.1 percent, an increase of 110 basis points over the prior year. Reported operating margin was 13.7 percent, up 290 basis points year-over-year, and adjusted operating margin increased 100 basis points to 14.5 percent as volume leverage and productivity initiatives more than offset inflation and unfavorable mix.
Measurement & Control Solutions
Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.
-
First quarter 2018 Measurement & Control Solutions revenue was
$371 million , up five percent organically versus the prior year period. This reflects solid growth in the Sensus business, up six percent year-over-year, primarily driven by strength inNorth America . Double-digit growth in the electric, gas and services businesses was partially offset by modest declines in the water sector, which primarily reflects the timing of large project deliveries inWestern Europe and theMiddle East in the year-ago period. Xylem’s legacy analytics business increased three percent organically in the quarter. -
First quarter reported operating income for the segment was
$33 million , and adjusted operating income, which excludes$10 million of restructuring and realignment costs and acquisition-related costs, was$43 million . Adjusted EBITDA for the Measurement & Control Solutions segment increased 270 basis points to 21.8 percent. Reported operating margin for the segment was 8.9 percent. Adjusted operating margin increased 90 basis points year-over-year to 11.6 percent as volume leverage and price combined with cost reductions more than offset inflation, the funding of strategic R&D investments and higher purchase accounting amortization.
Supplemental information on Xylem’s first quarter 2018 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.
About Xylem
Xylem (XYL) is a leading global water technology company committed to
developing innovative technology solutions to the world’s water
challenges. The Company’s products and services move, treat, analyze,
monitor and return water to the environment in public utility,
industrial, residential and commercial building services settings. Xylem
also provides a leading portfolio of smart metering, network
technologies and advanced infrastructure analytics solutions for water,
electric and gas utilities. The Company’s more than 16,500 employees
bring broad applications expertise with a strong focus on identifying
comprehensive, sustainable solutions. Headquartered in
The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.
Forward-Looking Statements
This press release contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.
These forward-looking statements include statements about the
capitalization of
XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) (in millions, except per share data) |
||||||||
For the three months ended March 31, | 2018 | 2017 | ||||||
Revenue | $ | 1,217 | $ | 1,071 | ||||
Cost of revenue | 757 | 659 | ||||||
Gross profit | 460 | 412 | ||||||
Selling, general and administrative expenses | 296 | 272 | ||||||
Research and development expenses | 41 | 42 | ||||||
Restructuring and asset impairment charges, net | 10 | 12 | ||||||
Operating income | 113 | 86 | ||||||
Interest expense | 21 | 20 | ||||||
Other non-operating income (expense), net | 3 | (1 | ) | |||||
Gain from sale of business | — | 5 | ||||||
Income before taxes | 95 | 70 | ||||||
Income tax expense | 16 | 14 | ||||||
Net income | $ | 79 | $ | 56 | ||||
Earnings per share: | ||||||||
Basic | $ | 0.44 | $ | 0.31 | ||||
Diluted | $ | 0.43 | $ | 0.31 | ||||
Weighted average number of shares: | ||||||||
Basic | 179.9 | 179.6 | ||||||
Diluted | 181.4 | 180.7 | ||||||
Dividends declared per share | $ | 0.2100 | $ | 0.1800 | ||||
XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in millions, except per share amounts) |
|||||||
March 31, 2018 |
December 31, 2017 |
||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 297 | $ | 414 | |||
Receivables, less allowances for discounts and doubtful accounts of $29 and $35 in 2018 and 2017, respectively | 999 | 956 | |||||
Inventories | 578 | 524 | |||||
Prepaid and other current assets | 192 | 177 | |||||
Total current assets | 2,066 | 2,071 | |||||
Property, plant and equipment, net | 666 | 643 | |||||
Goodwill | 3,082 | 2,768 | |||||
Other intangible assets, net | 1,303 | 1,168 | |||||
Other non-current assets | 233 | 210 | |||||
Total assets | $ | 7,350 | $ | 6,860 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 543 | $ | 549 | |||
Accrued and other current liabilities | 546 | 551 | |||||
Short-term borrowings and current maturities of long-term debt | 371 | — | |||||
Total current liabilities | 1,460 | 1,100 | |||||
Long-term debt | 2,228 | 2,200 | |||||
Accrued postretirement benefits | 446 | 442 | |||||
Deferred income tax liabilities | 285 | 252 | |||||
Other non-current accrued liabilities | 374 | 347 | |||||
Total liabilities | 4,793 | 4,341 | |||||
Stockholders’ equity: | |||||||
Common Stock – par value $0.01 per share: | |||||||
Authorized 750.0 shares, issued 192.8 shares and 192.3 shares in 2018 and 2017, respectively | 2 | 2 | |||||
Capital in excess of par value | 1,925 | 1,912 | |||||
Retained earnings | 1,282 | 1,227 | |||||
Treasury stock – at cost 12.8 shares and 12.4 shares in 2018 and 2017, respectively | (461 | ) | (428 | ) | |||
Accumulated other comprehensive loss | (207 | ) | (210 | ) | |||
Total stockholders’ equity | 2,541 | 2,503 | |||||
Non-controlling interests | 16 | 16 | |||||
Total equity | 2,557 | 2,519 | |||||
Total liabilities and stockholders’ equity | $ | 7,350 | $ | 6,860 | |||
XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions) |
|||||||
For the three months ended March 31, | 2018 | 2017 | |||||
Operating Activities | |||||||
Net income | $ | 79 | $ | 56 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation | 29 | 28 | |||||
Amortization | 38 | 31 | |||||
Share-based compensation | 9 | 6 | |||||
Restructuring and asset impairment charges | 10 | 12 | |||||
Gain from sale of business | — | (5 | ) | ||||
Other, net | (4 | ) | (2 | ) | |||
Payments for restructuring | (5 | ) | (8 | ) | |||
Changes in assets and liabilities (net of acquisitions): | |||||||
Changes in receivables | (9 | ) | (12 | ) | |||
Changes in inventories | (40 | ) | (10 | ) | |||
Changes in accounts payable | 6 | (32 | ) | ||||
Other, net | (50 | ) | (12 | ) | |||
Net Cash – Operating activities | 63 | 52 | |||||
Investing Activities | |||||||
Capital expenditures | (61 | ) | (43 | ) | |||
Acquisition of business, net of cash acquired | (430 | ) | (6 | ) | |||
Proceeds from sale of business | — | 11 | |||||
Net Cash – Investing activities | (491 | ) | (38 | ) | |||
Financing Activities | |||||||
Short-term debt issued, net | 371 | — | |||||
Short-term debt repaid | — | (5 | ) | ||||
Repurchase of common stock | (33 | ) | (5 | ) | |||
Proceeds from exercise of employee stock options | 3 | 1 | |||||
Dividends paid | (38 | ) | (33 | ) | |||
Other, net | (1 | ) | 1 | ||||
Net Cash – Financing activities | 302 | (41 | ) | ||||
Effect of exchange rate changes on cash | 9 | 6 | |||||
Net change in cash and cash equivalents | (117 | ) | (21 | ) | |||
Cash and cash equivalents at beginning of year | 414 | 308 | |||||
Cash and cash equivalents at end of period | $ | 297 | $ | 287 | |||
Supplemental disclosure of cash flow information: | |||||||
Cash paid during the period for: | |||||||
Interest | $ | 14 | $ | 12 | |||
Income taxes (net of refunds received) | $ | 17 | $ | 17 | |||
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, Sensus acquisition related costs, gain or loss from sale of businesses and special charges.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, adjusted net income and earnings per share, adjusted to exclude restructuring and realignment costs, Sensus acquisition related costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable. For Sensus historical adjustments, see Sensus Historical - Adjusted Operating Income table.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Sensus Acquisition Related Costs" defined as costs incurred by the Company associated with the acquisition of Sensus that are being reported within operating income. These costs include integration costs, acquisition costs, costs related to the recognition of the backlog intangible asset amortization recorded in purchase accounting.
“Special charges" defined as costs incurred by the Company, such as non-cash impairment charges, due diligence costs, initial acquisition and integration costs not related to Sensus and other special non-operating items.
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.
"Pro forma" defined as including the results of Sensus
for the calendar period prior to the acquisition of Sensus by
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||
Reported vs. Organic & Constant Currency Orders | |||||||||||||||||
($ Millions) | |||||||||||||||||
(As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | |||||||||||||||
(A) | (B) | (C) | (D) | (E) = B+C+D | (F) = E/A | (G) = (E - C) / A | |||||||||||
Change | % Change |
Acquisitions / |
Change | % Change | |||||||||||||
Orders | Orders | 2018 v. 2017 | 2018 v. 2017 |
Divestitures |
FX Impact | Adj. 2018 v. 2017 | Adj. 2018 v. 2017 | ||||||||||
2018 | 2017 | ||||||||||||||||
Quarter Ended March 31 |
|||||||||||||||||
Xylem Inc. | 1,320 | 1,137 | 183 | 16% | (8) | (56) | 119 | 10% | 11% | ||||||||
Water Infrastructure | 554 | 467 | 87 | 19% | - | (28) | 59 | 13% | 13% | ||||||||
Applied Water | 384 | 354 | 30 | 8% | 6 | (14) | 22 | 6% | 5% | ||||||||
Measurement & Control Solutions | 382 | 316 | 66 | 21% | (14) | (14) | 38 | 12% | 16% | ||||||||
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||
Reported vs. Organic & Constant Currency Revenue | |||||||||||||||||
($ Millions) | |||||||||||||||||
(As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | |||||||||||||||
(A) | (B) | (C) | (D) | (E) = B+C+D | (F) = E/A | (G) = (E - C) / A | |||||||||||
Change | % Change |
Acquisitions / |
Change | % Change | |||||||||||||
Revenue | Revenue | 2018 v. 2017 | 2018 v. 2017 |
Divestitures |
FX Impact | Adj. 2018 v. 2017 | Adj. 2018 v. 2017 | ||||||||||
2018 | 2017 | ||||||||||||||||
Quarter Ended March 31 |
|||||||||||||||||
Xylem Inc. | 1,217 | 1,071 | 146 | 14% | (15) | (54) | 77 | 7% | 9% | ||||||||
Water Infrastructure | 480 | 419 | 61 | 15% | - | (25) | 36 | 9% | 9% | ||||||||
Applied Water | 366 | 333 | 33 | 10% | 5 | (14) | 24 | 7% | 6% | ||||||||
Measurement & Control Solutions | 371 | 319 | 52 | 16% | (20) | (15) | 17 | 5% | 12% | ||||||||
Xylem Inc. Non-GAAP Reconciliation | |||||
Adjusted Operating Income | |||||
($ Millions) | |||||
Q1 | |||||
2018 |
2017 |
||||
Total Revenue | |||||
• Total Xylem | 1,217 | 1,071 | |||
• Water Infrastructure | 480 | 419 | |||
• Applied Water | 366 | 333 | |||
• Measurement & Control Solutions | 371 | 319 | |||
Operating Income | |||||
• Total Xylem | 113 | 86 | |||
• Water Infrastructure | 49 | 41 | |||
• Applied Water | 50 | 36 | |||
• Measurement & Control Solutions | 33 | 25 | |||
• Total Segments | 132 | 102 | |||
Operating Margin | |||||
• Total Xylem | 9.3% | 8.0% | |||
• Water Infrastructure | 10.2% | 9.8% | |||
• Applied Water | 13.7% | 10.8% | |||
• Measurement & Control Solutions | 8.9% | 7.8% | |||
• Total Segments | 10.8% | 9.5% | |||
Sensus Acquisition Related Costs | |||||
• Total Xylem | - | 10 | |||
• Water Infrastructure | - | - | |||
• Applied Water | - | - | |||
• Measurement & Control Solutions | - | 6 | |||
• Total Segments | - | 6 | |||
Special Charges | |||||
• Total Xylem | 6 | 5 | |||
• Water Infrastructure | - | - | |||
• Applied Water | - | 5 | |||
• Measurement & Control Solutions | 2 | - | |||
• Total Segments | 2 | 5 | |||
Restructuring & Realignment Costs | |||||
• Total Xylem | 16 | 11 | |||
• Water Infrastructure | 5 | 4 | |||
• Applied Water | 3 | 4 | |||
• Measurement & Control Solutions | 8 | 3 | |||
• Total Segments | 16 | 11 | |||
Adjusted Operating Income | |||||
• Total Xylem | 135 | 112 | |||
• Water Infrastructure | 54 | 45 | |||
• Applied Water | 53 | 45 | |||
• Measurement & Control Solutions | 43 | 34 | |||
• Total Segments | 150 | 124 | |||
Adjusted Operating Margin | |||||
• Total Xylem | 11.1% | 10.5% | |||
• Water Infrastructure | 11.3% | 10.7% | |||
• Applied Water | 14.5% | 13.5% | |||
• Measurement & Control Solutions | 11.6% | 10.7% | |||
• Total Segments | 12.3% | 11.6% | |||
|
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs. |
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||||
Adjusted Diluted EPS | |||||||||||||||||||
($ Millions, except per share amounts) | |||||||||||||||||||
Q1 2018 | Q1 2017 | ||||||||||||||||||
As Reported |
Adjustments |
Adjusted |
As Reported |
Adjustments |
Adjusted |
||||||||||||||
Total Revenue | 1,217 | 1,217 | 1,071 | 1,071 | |||||||||||||||
Operating Income | 113 | 22 |
a |
135 | 86 | 26 |
a |
112 | |||||||||||
Operating Margin | 9.3% | 11.1% | 8.0% | 10.5% | |||||||||||||||
Interest Expense | (21) | (21) | (20) | (20) | |||||||||||||||
Other Non-Operating Income (Expense) | 3 | 3 | (1) | (1) | |||||||||||||||
(Loss)/Gain from sale of business | - | - | 5 | (5) | - | ||||||||||||||
Income before Taxes | 95 | 22 | 117 | 70 | 21 | 91 | |||||||||||||
Provision for Income Taxes | (16) | (8) | b | (24) | (14) | (6) | b | (20) | |||||||||||
Net Income attributable to Xylem | 79 | 14 | 93 | 56 | 15 | 71 | |||||||||||||
Diluted Shares | 181.4 | 181.4 | 180.7 | 180.7 | |||||||||||||||
Diluted EPS | $ | 0.43 | $ | 0.08 | $ | 0.51 | $ | 0.31 | $ | 0.08 | $ | 0.39 | |||||||
Year-over-year currency translation impact on current year diluted EPS | $ | 0.05 | $ | 0.01 | $ | 0.06 | |||||||||||||
Diluted EPS at Constant Currency | $ | 0.38 | $ | 0.07 | $ | 0.45 | |||||||||||||
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs. | ||
a | Restructuring & realignment costs of $16 million and $11 million in 2018 and 2017, respectively; special charges of $6 million of acquisition costs in 2018 and $5 million of asset impairment in 2017 and Sensus acquisition related costs of $10 million in 2017. | |
b | Net tax impact on restructuring & realignment costs of $4 million and $2 million in 2018 and 2017, respectively; net tax impact on special charges of $1 million and $2 million in 2018 and 2017, respectively; net tax impact on Sensus acquisition related costs of $4 million and tax benefit of $2 million on the gain from sale of business in 2017 and tax-related special items of $3 million of expense in 2018. | |
Xylem Inc. Non-GAAP Reconciliation | ||||||||
Net Cash - Operating Activities vs. Free Cash Flow | ||||||||
($ Millions) | ||||||||
Q1 | ||||||||
2018 |
2017 |
|||||||
Net Cash - Operating Activities | $ | 63 | $ | 52 | ||||
Capital Expenditures | (61 | ) | (43 | ) | ||||
Free Cash Flow | $ | 2 | $ | 9 | ||||
Cash paid for Sensus acquisition related costs | (1 | ) | (17 | ) | ||||
Free Cash Flow, excluding Sensus Acquisition Related Costs | $ | 3 | $ | 26 | ||||
Net Income | 79 | 56 | ||||||
Gain/(Loss) from sale of businesses | - | 5 | ||||||
Special Charges - non-cash impairment and early debt extinguishment | - | (5 | ) | |||||
Sensus acquisition related costs | - | (10 | ) | |||||
Net Income, excluding gain on sale of businesses, non-cash impairment charges and Sensus Acquisition Related Costs | $ | 79 | $ | 66 | ||||
Free Cash Flow Conversion | 4 | % | 39 | % | ||||
Xylem Inc. Non-GAAP Reconciliation | ||||||||||
EBITDA and Adjusted EBITDA by Quarter | ||||||||||
($ Millions) | ||||||||||
2018 | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
Net Income | 79 | 79 | ||||||||
Income Tax Expense | 16 | 16 | ||||||||
Interest Expense (Income), net | 20 | 20 | ||||||||
Depreciation | 29 | 29 | ||||||||
Amortization | 38 | 38 | ||||||||
EBITDA | 182 | - | - | - | 182 | |||||
Share-based Compensation | 9 | 9 | ||||||||
Restructuring & Realignment | 16 | 16 | ||||||||
Gain on sale of business | - | - | ||||||||
Sensus Acquisition Related Costs | - | - | ||||||||
Special Charges | 6 | 6 | ||||||||
Adjusted EBITDA | 213 | - | - | - | 213 | |||||
Revenue | 1,217 | 1,217 | ||||||||
Adjusted EBITDA Margin | 17.5% | 17.5% | ||||||||
2017 | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
Net Income | 56 | 100 | 104 | 70 | 330 | |||||
Income Tax Expense | 14 | 21 | 27 | 74 | 136 | |||||
Interest Expense (Income), net | 20 | 20 | 20 | 19 | 79 | |||||
Depreciation | 28 | 27 | 28 | 26 | 109 | |||||
Amortization | 31 | 30 | 30 | 34 | 125 | |||||
EBITDA | 149 | 198 | 209 | 223 | 779 | |||||
Share-based Compensation | 6 | 5 | 5 | 5 | 21 | |||||
Restructuring & Realignment | 11 | 12 | 9 | 9 | 41 | |||||
Gain on sale of business | (5) | - | 1 | 14 | 10 | |||||
Sensus Acquisition Related Costs | 7 | 2 | 3 | 2 | 14 | |||||
Special Charges | 5 | - | 3 | 5 | 13 | |||||
Adjusted EBITDA | 173 | 217 | 230 | 258 | 878 | |||||
Revenue | 1,071 | 1,164 | 1,195 | 1,277 | 4,707 | |||||
Adjusted EBITDA Margin | 16.2% | 18.6% | 19.2% | 20.2% | 18.7% | |||||
Xylem Inc. Non-GAAP Reconciliation | ||||||||||
EBITDA and Adjusted EBITDA by Quarter | ||||||||||
Water Infrastructure | ||||||||||
($ Millions) | ||||||||||
2018 | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
Pre-Tax Income | 47 | 47 | ||||||||
Interest Expense (Income), net | - | - | ||||||||
Depreciation | 12 | 12 | ||||||||
Amortization | 5 | 5 | ||||||||
EBITDA | 64 | - | - | - | 64 | |||||
Share-based Compensation | 1 | 1 | ||||||||
Restructuring & Realignment | 5 | 5 | ||||||||
Adjusted EBITDA | 70 | - | - | - | 70 | |||||
Revenue | 480 | 480 | ||||||||
Adjusted EBITDA Margin | 14.6% | 14.6% | ||||||||
2017 | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
Pre-Tax Income | 39 | 73 | 90 | 105 | 307 | |||||
Interest Expense (Income), net | - | - | (1) | (1) | (2) | |||||
Depreciation | 11 | 11 | 12 | 11 | 45 | |||||
Amortization | 5 | 4 | 5 | 5 | 19 | |||||
EBITDA | 55 | 88 | 106 | 120 | 369 | |||||
Share-based Compensation | 1 | - | - | 1 | 2 | |||||
Restructuring & Realignment | 4 | 5 | 3 | 4 | 16 | |||||
Adjusted EBITDA | 60 | 93 | 109 | 125 | 387 | |||||
Revenue | 419 | 482 | 520 | 583 | 2,004 | |||||
Adjusted EBITDA Margin | 14.3% | 19.3% | 21.0% | 21.4% | 19.3% | |||||
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs. |
Xylem Inc. Non-GAAP Reconciliation | ||||||||||
EBITDA and Adjusted EBITDA by Quarter | ||||||||||
Applied Water | ||||||||||
($ Millions) | ||||||||||
2018 | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
Pre-Tax Income | 50 | 50 | ||||||||
Interest, net | - | - | ||||||||
Depreciation | 5 | 5 | ||||||||
Amortization | - | - | ||||||||
EBITDA | 55 | - | - | - | 55 | |||||
Share-based Compensation | 1 | 1 | ||||||||
Restructuring & Realignment | 3 | 3 | ||||||||
Adjusted EBITDA | 59 | - | - | - | 59 | |||||
Revenue | 366 | 366 | ||||||||
Adjusted EBITDA Margin | 16.1% | 16.1% | ||||||||
2017 | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
Pre-Tax Income | 40 | 49 | 49 | 62 | 200 | |||||
Interest, net | - | - | - | - | - | |||||
Depreciation | 5 | 5 | 5 | 5 | 20 | |||||
Amortization | 1 | 1 | 1 | - | 3 | |||||
EBITDA | 46 | 55 | 55 | 67 | 223 | |||||
Share-based Compensation | - | 1 | 1 | - | 2 | |||||
Restructuring & Realignment | 4 | 5 | 5 | 3 | 17 | |||||
Gain on sale of business | (5) | - | 1 | (2) | (6) | |||||
Special Charges | 5 | - | - | - | 5 | |||||
Adjusted EBITDA | 50 | 61 | 62 | 68 | 241 | |||||
Revenue | 333 | 361 | 354 | 373 | 1,421 | |||||
Adjusted EBITDA Margin | 15.0% | 16.9% | 17.5% | 18.2% | 17.0% | |||||
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs. |
Xylem Inc. Non-GAAP Reconciliation | ||||||||||
EBITDA and Adjusted EBITDA by Quarter | ||||||||||
Measurement & Control Solutions | ||||||||||
($ Millions) | ||||||||||
2018 | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
Pre-Tax Income | 33 | 33 | ||||||||
Interest Expense (Income), net | - | - | ||||||||
Depreciation | 8 | 8 | ||||||||
Amortization | 29 | 29 | ||||||||
EBITDA | 70 | - | - | - | 70 | |||||
Share-based Compensation | 1 | 1 | ||||||||
Restructuring & Realignment | 8 | 8 | ||||||||
Special Charges | 2 | 2 | ||||||||
Adjusted EBITDA | 81 | - | - | - | 81 | |||||
Revenue | 371 | 371 | ||||||||
Adjusted EBITDA Margin | 21.8% | 21.8% | ||||||||
2017 | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
Pre-Tax Income | 24 | 30 | 26 | 11 | 91 | |||||
Interest Expense (Income), net | - | - | - | (1) | (1) | |||||
Depreciation | 8 | 8 | 7 | 7 | 30 | |||||
Amortization | 23 | 22 | 22 | 25 | 92 | |||||
EBITDA | 55 | 60 | 55 | 42 | 212 | |||||
Share-based Compensation | - | 1 | - | 1 | 2 | |||||
Restructuring & Realignment | 3 | 2 | 1 | 2 | 8 | |||||
Sensus Acquisition Related Costs | 3 | 1 | 2 | 1 | 7 | |||||
Adjusted EBITDA | 61 | 64 | 58 | 64 | 247 | |||||
Revenue | 319 | 321 | 321 | 321 | 1,282 | |||||
Adjusted EBITDA Margin | 19.1% | 19.9% | 18.1% | 19.9% | 19.3% | |||||
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20180501005858/en/
Source:
Xylem Inc.
Media:
Kelly McAndrew, +1-914-323-5969
Kelly.McAndrew@xyleminc.com
or
Investors:
Matt
Latino, +1-914-323-5821
Matthew.Latino@xyleminc.com